Schonfeld Strategic Advisors »

Peregrine Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $159k 25k 6.50
2023-09-30 $493k 52k 9.44
2023-06-30 $913k 65k 13.97
2023-03-31 $6.1M 323k 18.76
2022-12-31 $3.0M 221k 13.77
2022-09-30 $3.5M 183k 19.12
2022-06-30 $1.5M 100k 15.25
2022-03-31 $603k 30k 20.37
2021-12-31 $1.6M 53k 29.19
2021-09-30 $1.6M 72k 21.57
2021-06-30 $2.4M 94k 25.65
2021-03-31 $4.6M 252k 18.23
2020-12-31 $1.2M 104k 11.54
2020-09-30 $997 88k 0.01
2020-06-30 $259k 39k 6.57
2019-12-31 $219k 29k 7.66
2019-09-30 $280k 53k 5.30
2019-03-31 $1.9M 443k 4.25
2018-12-31 $2.7M 671k 4.10
2018-09-30 $4.7M 692k 6.86
2018-06-30 $196k 50k 3.92